Literature DB >> 8520159

Severity and predicted outcome of postoperative Pseudomonas aeruginosa infections.

T Kodama1, T Yokoyama, Y Takesue, M Okita, A Nakamitsu, E Hiyama, Y Imamura, T Santo, Y Murakami, H Tsumura.   

Abstract

The severity and predicted outcome of postoperative Pseudomonas aeruginosa (P. aeruginosa) infections (PPAI) was evaluated using a severity scoring system based on a simplification and modification of the APACHE II system. A total of 86 patients in whom P. aeruginosa was isolated from various sources were examined. PPAI developed in 50 patients, resulting in an overall mortality rate of 24%. An increased severity score (SS) correlated with an increased risk of developing PPAI. Thus, PPAI developed in 33% of the patients with an SS of 0-1, in 66.7% of those with an SS of 2-3, and in 100% of those with an SS of 6 or higher. Moreover, the mortality rate of the patients with an initial score of 6 or higher was 50%. The mean (+/- SD) initial severity score was 5.4 +/- 2.9 for survivors and 2.9 +/- 2.6 for nonsurvivors (P < 0.01). In the patients who subsequently died, the SS remained high throughout the clinical course despite therapy, whereas in the survivors the SS decreased progressively, reflecting a favorable clinical course. These results suggest that our severity scoring system was useful for predicting outcome and monitoring the response of PPAI to therapy.

Entities:  

Mesh:

Year:  1995        PMID: 8520159     DOI: 10.1007/BF00311481

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  18 in total

1.  Antibiotic therapy for Pseudomonas aeruginosa bacteremia: outcome correlations in a prospective study of 200 patients.

Authors:  M Hilf; V L Yu; J Sharp; J J Zuravleff; J A Korvick; R R Muder
Journal:  Am J Med       Date:  1989-11       Impact factor: 4.965

2.  Clinical outcome of seriously ill surgical patients with intra-abdominal infection depends on both physiologic (APACHE II score) and immunologic (DTH score) alterations.

Authors:  D Poenaru; N V Christou
Journal:  Ann Surg       Date:  1991-02       Impact factor: 12.969

3.  Changing patterns in surgical infections.

Authors:  W A Altemeier; R P Hummel; E O Hill; S Lewis
Journal:  Ann Surg       Date:  1973-10       Impact factor: 12.969

4.  Prevention of pseudomonas respiratory infection in a surgical intensive care unit.

Authors:  H C Polk; S Borden; J A Aldrete
Journal:  Ann Surg       Date:  1973-05       Impact factor: 12.969

5.  Severity of illness in intra-abdominal infection. A comparison of two indexes.

Authors:  T Skau; P O Nyström; C Carlsson
Journal:  Arch Surg       Date:  1985-02

6.  Severity of underlying disease as a predictor of nosocomial infection. Utility in the control of nosocomial infection.

Authors:  M R Britt; C J Schleupner; S Matsumiya
Journal:  JAMA       Date:  1978-03-13       Impact factor: 56.272

7.  Comparison of the local and systemic effects of sepsis in predicting survival.

Authors:  G A Ponting; A J Sim; H A Dudley
Journal:  Br J Surg       Date:  1987-08       Impact factor: 6.939

8.  APACHE-acute physiology and chronic health evaluation: a physiologically based classification system.

Authors:  W A Knaus; J E Zimmerman; D P Wagner; E A Draper; D E Lawrence
Journal:  Crit Care Med       Date:  1981-08       Impact factor: 7.598

9.  Efficacy of anti-endotoxin monoclonal antibody E5 alone or in combination with ciprofloxacin in neutropenic rats with Pseudomonas sepsis.

Authors:  R L Romulo; J E Palardy; S M Opal
Journal:  J Infect Dis       Date:  1993-01       Impact factor: 5.226

10.  Use of physiologic monitoring to predict outcome and to assist in clinical decisions in critically ill postoperative patients.

Authors:  W C Shoemaker; P Appel; R Bland
Journal:  Am J Surg       Date:  1983-07       Impact factor: 2.565

View more
  1 in total

1.  Postoperative enteritis caused by methicillin-resistant Staphylococcus aureus.

Authors:  T Kodama; T Santo; T Yokoyama; Y Takesue; E Hiyama; Y Imamura; Y Murakami; H Tsumura; K Shinbara; N Tatsumoto; Y Matsuura
Journal:  Surg Today       Date:  1997       Impact factor: 2.549

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.